- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 17/06 - Peptides being immobilised on, or in, an organic carrier attached to the carrier via a bridging agent
Patent holdings for IPC class C07K 17/06
Total number of patents in this class: 171
10-year publication summary
|
19
|
8
|
10
|
6
|
14
|
11
|
19
|
13
|
4
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Ablevia Biotech GmbH | 24 |
13 |
| The Trustees of the University of Pennsylvania | 4273 |
7 |
| The University of Melbourne | 523 |
5 |
| AbGenomics International Inc. | 6 |
4 |
| BioAlliance C.V. | 10 |
4 |
| Immunwork Inc. | 25 |
4 |
| Takara Bio USA, Inc. | 160 |
4 |
| Targimmune Therapeutics AG | 35 |
4 |
| Alphathera, LLC | 8 |
4 |
| Artificial Cell Technologies, Inc. | 38 |
3 |
| Bioright Worldwide Company Limited | 43 |
3 |
| F. Hoffmann-La Roche AG | 7951 |
2 |
| The Regents of the University of California | 19572 |
2 |
| Boehringer Ingelheim Vetmedica GmbH | 1288 |
2 |
| Amgen Inc. | 3904 |
2 |
| Wisconsin Alumni Research Foundation | 3838 |
2 |
| Board of Regents, The University of Texas System | 5641 |
2 |
| Bio-Thera Solutions, Ltd., Co. | 27 |
2 |
| Biotix, Inc. | 182 |
2 |
| Kode Biotech Limited | 22 |
2 |
| Other owners | 98 |